https://www.selleckchem.com/products/GDC-0879.html
1% vs 89.3% for 1 year, P=0.041; 68.7% vs 61.2% for 3 years, P=0.035). In addition, the patients in ERAS group had lower incidences of postoperative hemorrhage, bile leak, and postoperative deep vein thrombosis/pulmonary embolism (DVT/PE), decreased 30-day readmission rate and total readmission rate, and shorter LOS. ERAS program could be safely applied to patients who underwent hepatectomy thereby improving their recovery and prolonging OS and DFS. ERAS program could be safely applied to patients who underwent hepatectomy thereby impr
Like
Comment
Share
